EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA

Xue Zhang, Laura M Hack, Claire Bertrand, Rachel Hilton, Nancy J Gray, Leyla Boyar, Jessica Laudie, Boris D Heifets, Trisha Suppes, Peter J van Roessel, Carolyn I Rodriguez, Karl Deisseroth und 2 weitere

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.7803 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Xue Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California. Hauptthemen laut MEDLINE: N-Methyl-3,4-methylenedioxyamphetamine, Affect, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Rapidly acting therapeutics like 3,4-methylenedioxymethamphetamine (MDMA) are promising treatments for disorders such as posttraumatic stress disorder (PTSD). However, understanding who benefits most and the underlying neural mechanisms remains a critical gap. Stratifying individuals by neural circuit profiles could help differentiate neural, behavioral, and affective responses to MDMA, enabling personalized treatment strategies.

Objective

To investigate whether baseline stratification of individuals based on negative affect circuit profiles, particularly in response to nonconscious threat stimuli, can differentiate acute responses to MDMA. Design, Setting, and Participants This randomized clinical trial, implementing a double-blinded, within-participant, placebo- and baseline-controlled design, was conducted at Stanford University School of Medicine between November 2, 2021, and November 9, 2022, for wave 1 data collection. Participants had used MDMA on at least 2 prior occasions, but not in the past 6 months, and had subthreshold PTSD symptoms and early life trauma but no current psychiatric disorders. Data were analyzed from March 1, 2023, to January 1, 2024.

Interventions

Participants completed 4 visits: 1 baseline session followed by 1 placebo session and 2 MDMA sessions in a randomized order, totaling 64 visits. Baseline functional magnetic resonance imaging (fMRI) assessed the negative affect circuit using a nonconscious threat processing task (NTN). Main Outcomes and Measures Primary outcomes included activity and connectivity of amygdala and subgenual anterior cingulate cortex (sgACC) defining the negative affect circuit. Secondary outcomes were behavioral measures of implicit threat bias, likability of threat expressions, and affective assessments.

Results

Sixteen participants (10 [63%] female; mean [SD] age, 40.8 [7.6] years) were stratified into subgroups with high and low levels of NTN activity in the amygdala (NTN A+ [n = 8] and NTN A− [n = 8], respectively), based on a median split of baseline nonconscious threat-evoked fMRI responses. Following administration of the 120 mg of MDMA vs placebo, the NTN A+ subgroup showed significant reductions in amygdala (contrast estimate [CE], −1.43; 95% CI, −2.60 to −0.27; Cohen d , −1.22; P = .02) and sgACC activity (CE, −1.48; 95% CI, −2.42 to −0.54; Cohen d , −1.56; P = .004), increased sgACC-amygdala connectivity (CE, 0.65; 95% CI, 0.02-1.28; Cohen d , 1.02; P = .04), and increased likability of threat expressions (CE, 14.38; 95% CI, 1.46-27.29; Cohen d , 0.86; P = .03) compared with the NTN A− subgroup. Conclusions and Relevance In this randomized clinical trial of MDMA’s acute profiles, 120 mg of MDMA acutely normalized negative affect circuit reactivity in participants stratified by heightened amygdala reactivity at baseline, demonstrating the potential of neuroimaging to identify prospective biomarkers and guide personalized MDMA-based therapies. Trial Registration ClinicalTrials.gov Identifier: NCT04060108

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Methyl-3,4-methylenedioxyamphetamineAffectStress Disorders, Post-TraumaticHumansFemaleMaleAdultDouble-Blind MethodMagnetic Resonance ImagingBrainHallucinogensMiddle AgedAmygdalaYoung AdultGyrus Cinguli

Substanzen

N-Methyl-3,4-methylenedioxyamphetamineHallucinogens

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
  • Sierra-Pacific Mental Illness Research, Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
  • Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
  • Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
  • Department of Bioengineering, Stanford University, Stanford, California.
  • Howard Hughes Medical Institute, Stanford University, Stanford, California.

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Zhang, X., Hack, L. M., Bertrand, C., Hilton, R., Gray, N. J., Boyar, L., Laudie, J., Heifets, B. D., Suppes, T., van Roessel, P. J., Rodriguez, C. I., Deisseroth, K., Knutson, B., & Williams, L. M. (2025). Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.7803

Vancouver

Zhang X, Hack LM, Bertrand C, Hilton R, Gray NJ, Boyar L, et al. Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.7803

BibTeX
@article{Zhang2025,
  author = {Zhang, Xue and Hack, Laura M and Bertrand, Claire and Hilton, Rachel and Gray, Nancy J and Boyar, Leyla and Laudie, Jessica and Heifets, Boris D and Suppes, Trisha and van Roessel, Peter J and Rodriguez, Carolyn I and Deisseroth, Karl and Knutson, Brian and Williams, Leanne M},
  title = {Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.7803}
}
Kostenlos starten →